1. Kumasaka N, Sakuma M, Shirato K. Incidence of pulmonary thromboembolism in Japan. Jpn Circ J 1999; 63:
439-441.
2. Sakuma M, Nakamura M, Yamada N, et al. Venous thromboembolism-Deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, pulmonary embolism alone. Circ J 2009; 73: 305-309.
3. Freiman DG, Suyemoto J, Wessler S, et al. Frequency of pulmonary thromboembolism in man. N Engl J Med. 1965;
272: 1278-1280.
4. Morrell MT, Dunnill MS. The post-mortem incidence of pulmonary embolism in a hospital population. Br J Surg 1968; 55: 347-352.
5. 中野 赳，伊藤早苗，竹沢英郎．肺塞栓症の疫学．日本 医事新報 1980; 2949: 43-47.
6. 中村陽一，由谷親夫，今北正美，他．肺梗塞発生に至る 静脈血栓症および肺血栓塞栓症の病理組織学的研究．静脈 学 1996; 7: 17-22.
7. 三重野龍彦，北村 諭．わが国の実態．呼吸と循環 1989; 37: 923-927.
8. 佐久間聖仁，高橋 徹，北向 修，他．日本病理剖検輯 報による肺塞栓症症例頻度の推移．日呼吸会誌 2001; 39（増 刊号）: 133.
9. 古家 仁，瀬尾憲正，北口勝康，他．社団法人日本麻酔 科学会周術期肺塞栓症調査2005年結果（短報）Therapeutic research 2008; 29: 659-661.
10. Nakamura M, Fujioka H, Yamada N, et al. Clinical characteristics of acute pulmonary thromboembolism in Japan: results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research. Clin Cardiol 2001; 24:
132-138.
11. 應儀成二，平井正文，太田 敬，他．肺塞栓症―第一報
― 本 邦 に お け る 静 脈 疾 患 に 関 す るSurvey IV． 静 脈 学 2000; 11: 59-65.
12. Yamada N, Nakamura M, Ishikura K, et al. Triggers of acute pulmonary thromboembolism developed in hospital, with focusing on toilet activities as triggering acts. Int J Caldiol 2005; 98: 409-411.
13. Elliott CG. Pulmonary physiology during pulmonary embolism. Chest 1992; 101 (Supplement): 163S-171S.
14. Ansari A. Acute and chronic pulmonary thromboembolism:
current perspectives. Part I I: etiology, pathology, pathogenesis, and pathophysiology. Clin Cardiol 1986; 9:
449-456.
15. Moser KM. Pulmonary embolism. Am Rev Respir Dis 1977; 115: 829.
16. Hyland JW, Smith GT, Dexter L, et al. Effect of selective embolization of various sized pulmonary arteries in dogs. Am J Physiol 1963; 204: 619.
17. McIntyre KM, Sasahara AA, Sharma GV. Pulmonary thromboembolism; Current concepts. Adv Intern Med 1972;
18: 199-218.
18. Sharma G, McIntyre KM, Sharma S, et al. Clinical and hemodynamic correlates in pulmonary embolism. Clin Chest Med 1984; 5: 421-428.
19. Sekioka K, Tanaka T, Nakano T, et al. Right ventricular function under acute cor pulmonale. Jpn Circ J 1989; 53:
1269-1277.
20. Sharma GV, Sasahara AA. Regional and transmural myocardial blood flow studies in experimental pulmonary embolism. Prog Cardiovasc Dis 1974; 17: 191-198.
21. Visner M, Arentzen CE, Anderson RW, et al. Alteration in left ventricular three-dimentional dynamic geometry and systolic function during acute right ventricular hypertension in the conscious dog. Circulation 1983; 67: 353-365.
22. Stein M, Thomas D, Tanabe G, et al. Humoral factors in experimental pulmonary embolism. J Clin Invest 1963; 42:
982.
23. Rosoff CB, Salzman EM, Gruewich V. Reduction of the platelet serotonin and response of pulmonary emboli. Surgery 1971; 70: 12-19.
24. Vaage J. Vagal reflexes in the bronchoconstriction occurring after induced intravascular platelet aggregation.
Acta Physiol Scand 1976; 97: 94-103.
25. Morgan TE, Edmunds LH Jr. Pulmonary artery occlusion.
III Biochemical alterations. J Appl Physiol 1967; 22: 1012-1016.
26. Parker BM, Smith JR. Pulmonary embolism and infarction.
Am J Med 1958; 24: 402-427.
27. Tsao MS, Schraufnagel D, Wong NS. Pathogenesis of pulmonary infarction. Am J Med 1982; 72: 599-608.
28. Butler J, Kowalski TF, Willoughly S, et al. Preventing infarctions after pulmonary artery occlusion [abstract]. Clin Res 1989; 37: 163A.
29. Dalen JE, Heffakee CI, Alpert JS, et al. Pulmonary embolism, pulmonary hemorrage, and pulmonary infarction.
N Engl J Med 1977; 296: 1431-1435.
30. Schraufnagel DE, Tsao MS, Yas YT, et al. Factors associated with pulmonary infarction: a discriminant analysis study. Am J Clin Pathol 1985; 84: 15-18.
31. Konstantinides S, Geibel A, Kasper W, et al. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 1998; 97: 1946-1951.
32. Task Force on Pulmonary Embolism, European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 2000; 21: 1301-1336.
33. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2008; 29: 2276-2315.
34. Goldhaber SZ, Morpurgo M. Diagnosis, treatment and
prevention of pulmonary embolism. Report of the WHO/ISFC Task Force. JAMA 1992; 268: 1727-1733.
35. Barritt DW, Jordan SC. Clinical features of pulmonary embolism. Lancet 1961; 1: 729-732.
36. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;
9162: 1386-1389.
37. Chartier L, Bera J, Delomez M, et al. Free-floating thrombi in the right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients. Circulation 1999; 99:
2779-2783.
38. Giannitsis E, Muller-bardorff M, Kurowski, et al.
Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102:
211-217.
39. Poe ND, Dore EK, Swanson LA, et al. Fatal pulmonary embolism. J Nucl Med 1969; 10: 28-33.
40. 児島正純，池田聡司，宮原嘉之，他．本邦における肺血 栓塞栓症の予後について．Therapeutic research 2002; 23:
635-637.
41. The urokinase pulmonary embolism trial. A national cooperative study: Circulation 1973; 47 (Suppl): II1-108.
42. Paraskos JA, Adelstein SJ, Smith RE, et al. Late prognosis of acute pulmonary embolism. N Engl J Med 1973; 289: 55-58.
43. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1990;
81: 1735-1743.
44. Jamieson SW, Kapelanski DP. Pulmonary endarterectomy.
Curr Probl Surg 2000; 37: 165-252.
45. Pengo V, Lensing AWA, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257-2264.
46. Lapostolle F, Surget V, Borron SW, et al. Severe pulmonary embolism associated with air travel. N Engl J Med 2001; 345:
779-783.
47. 三浦靖彦，森尾比呂志，畑典武，他．第47回日本宇宙 航空環境医学会総会予稿集 2001; 33.
48. Daily PO, Dembitsky WP, Peterson KL, et al. Modifications o f t e c h n i q u e s a n d e a r l y r e s u l t s o f p u l m o n a r y thromboendarterectomy for chronic pulmonary embolism. J Thorac Cardiovasc Surg 1987; 93: 221-233.
49. Riedel M, Stanek V, Widimsky J, et al. Longterm follow-up of patients with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respiratory data. Chest 1982; 81: 151-158.
50. 中西宣文，京谷晋吾，佐藤 徹，他．慢性肺血栓塞栓症 例の肺血行動態と長期予後に関する検討．日胸疾会誌 1997; 35: 589-595.
51. Jamieson SW, Auger WR, Fedullo PF, et al. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29 month period. J Thorac Cardiovasc Surg 1993; 106: 116-127.
52. Archibald CJ, Auger WR, Fedullo PF, et al. Lon-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1999; 160: 523-528.
53. Tanabe N, Nakagawa Y, Masuda M, et al. The efficacy of pulmonary thromboendarterectomy on long-term gas exchange. Eur Respir J 1997; 10: 2066-2072.
54. Ando M, Okita Y, Tagusari O, et al. Surgical treatment for chronic thromboembolic pulmonary hypertension under profound hypothermia and circulatory arrest in 24 patients. J Card Surg 1999; 14: 377-385.
55. Ogino H, Ando M, Matsuda H, et al. Japanese single-center experience of surgery for chronic thromoboembolic pulmonary hypertension. Ann Thorac Surg 2006; 82: 630-636.
56. 田邉信宏，巽浩一郎，栗山喬之，他．特発性慢性肺血栓 塞栓症（肺高血圧型）ガイドライン改定の要点．厚生労働 科学研究費助成金難治性疾患克服研究事業「呼吸不全に関 する調査研究」平成18年度研究報告書 2007: 175-177.
57. Yoshimi S, Tanabe N, Masuda M, et al. Survival and quality of life in peripheral type chronic thromboembolic pulmonary hypertension. Circ J 2008; 72: 958-966.
58. 三重野龍彦，青木茂行，管間康夫，他．肺血栓塞栓症 1.本邦における肺血栓塞栓症の疫学的検討（日本病理剖検 輯報に基づいて）．日胸疾会誌1988; 26: 448-456.
59. 栗山喬之．総括報告．慢性血栓塞栓性肺高血圧症診断基 準．厚生省特定疾患呼吸不全調査研究班平成8年度研究報 告書 1997: 1-9.
60. 橋本修二，巽浩一郎，岡田修，他．呼吸不全における特 定疾患の全国推計患者数．日呼吸会誌1998; 36: 1006-1010.
61. 田辺信宏，岡田修，巽浩一郎，他．呼吸不全6疾患の全 国疫学調査．わが国における慢性血栓塞栓性肺高血圧症の 検討．厚生省特定疾患呼吸器系疾患調査研究班呼吸不全調 査研究班平成9年度研究報告書 1998: 129-131.
62. 田邉信宏，笠原靖紀，巽浩一郎，他．慢性血栓塞栓性肺 高血圧症臨床調査個人票による解析.厚生労働科学研究費 助成金難治性疾患克服研究事業「呼吸不全に関する調査研 究」平成19年度研究報告書 2008: 136-139.
63. Morris TA, Marsh JJ, Chilles PG, et al. Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis. Am J Respir Crit Care Med 2006; 173: 1270-1275.
64. Gallie N, Kim NHS. Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension. Pro Am Thorac Soc 2006; 3: 571-576.
65. Du L, Sullivan CC, Chu D, et al. Signaling molecules in nonfamilial pulmonary hypertension. New Engl J Med 2003;
348: 500-509.
66. Tanabe N, Kimura A, Amano S et al. Association of clinical features with HLA in chronic pulmonary thromboembolism in Japan. Eur Respir J 2005; 25: 131-138.
67. Bergin CJ, Cirlin C, Deutsch R, et al. Predictors of patient response to pulmonary thromboendarterectomy. AJR 2000;
174: 509-515.
68. Ono, F, Nagaya, N, Okumura, H, et al. Effect of orally
active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction. Chest 2003; 123: 1583-1588.
69. Hughes RJ, Jais X, Bonderman D et al. The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study. Eur Respir J 2006;
28: 138-143.
70. Reichenberger F, Voswinckel R, Enke B, et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J 2007;30: 922-927.
71. Condliffe R, Kiely DG, Gibbs SR, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertesion. Am J Respir Crit Care Med 2008; 177: 122-1127.
72. Browse NL, Burnand KG, Irvine AT, et al. Deep vein thrombosis: pathology and diagnosis. Browse NL, et al. (eds), Diseases of the Veins, London, Arnold 1999: 249-291.
73. Meissner MH, Wakefield TW, Ascher E, et al. Acute venous disease: Venous thrombosis and venous trauma. J Vasc Surg 2007; 46: 25S-53S.
74. Sevitt S, Gallender N. Venous thrombosis and pulmonary embolism: A clinico-pathological study in injured and burned patients. Br J Surg 1961; 48: 475-489.
75. Saeger W, Genzkow M. Venous thromboses and pulmonary embolisms in post-mortem series: probable causes by correlations of clinical data and basic diseases. Pathol Res Pract 1994; 190: 394-399.
76. Hirst A, Gore I, Tanaka K, et al. Myocardial infarction and pulmonary embolism. Arch Pathol 1965; 80: 365-367.
77. 三島好雄，他．厚生省特定疾患系統的脈管障害調査研究 班1988年調査報告書．
78. 星野俊一，佐戸川弘之．深部静脈血栓症，本邦における 静脈疾患に関するSurveyⅠ．静脈学 1997; 8: 307-311.
79. Coon WW, Willis PW, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation 1973; 48: 839-846.
80. Anderson FA, Wheeler HB, Goldberg RJ, et al. Population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. Arch Intern Med 1991; 151: 933-938.
81. Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein thrombosis in the general population: systemic review. Eur J Vasc Endovasc Surg 2003; 25: 1-5.
82. Meissner MH, Strandness JR, DE. The epidemiology and natural history of acute deep vein thrombosis. Gloviczki P, et al. (eds), Handbook of venous disorders. Arnold, Yew York 2001: 38-48.
83. Well PS, Hirsh J, Anderson DR, et al. Accuracy of clinical assessment of deep vein thrombosis. Lancet 1995; 345: 1326-1330.
84. Gallus AS, Salzman EW, Hirsh J. Prevention of venous thromboembolism. Venous thrombosis. Br J Surg 1985; 72:
912-915.
85. Nicolaides AN, Breddin HK, Fareed J, et al. Prevention of
venous thromboembolism. International consensus statement.
Guidelines complied in accordance with the scientific evidence. Int Angiol 2001; 20: 1-37.
86. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism-six ACCP consensus conference on antithrombotic therapy. Chest 2001; 119: 132S-175S.
87. 肺血栓塞栓省/深部静脈血栓症（静脈血栓塞栓症）予防 ガイドライン作成委員会．肺血栓塞栓症/深部静脈血栓症
（ 静 脈 血 栓 塞 栓 症 ） 予 防 ガ イ ド ラ イ ン．Medical Front Internatonal Limited, 東京 2004.
88. Hill SL, Holtzman GI, Martin D, et al. The origin of lower extremity deep vein thrombosis in acute venous thrombosis.
Amer J Surg 1997; 173: 485-490.
89. Iwai T, Sato S, Yamada T, et al. Popliteal vein entrapment caused by the third head of the gastrocnemius muscle. Br J Surg 1987; 74: 1006-1008.
90. Ohgi S, Tachibana M, Ikebuchi M, et al. Pulmonary embolism in patients with isolated soleal vein thrombosis.
Angiology 1998; 49: 759-764.
91. Lohr JM, James KV, Deshmukh RM, et al. Calf vein thrombi are not a benign finding. Amer J Surg 1995; 170: 86-90.
92. Ohgi S, Tachibana M, Ikebuchi, et al. Exploration of pulmonary embolic sources in the lower limbs by ultrasonography. Nakano T, et al. (eds), Pulmonary embolism, Tokyo, Springer-Verlag Tokyo 1999: 57-66.
93. Ro A, Kageyama N, Tanifuji T, et al. Pulmonary thromboembolism: Overview and update from medicolegal aspects. Legal Medicine 2008; 10: 57-71.
94. Kageyama N, Ro A, Tanifuji T, et al. Significance of the soleal vein and its drainage veins in cases of massive pulmonary thromboembolism. Annals of Vascular Diseases 2008; 1: 35-39.
95. Myers DD, Jr., Schaub R, Wrobleski SH, et al. P-selection antagonism causes dose-dependent venous thrombosis inhibition. Thromb Haemost 2001; 85: 423-429.
96. Sabatier F, Roux V, Anfosso F, et al. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. B ｌood 2002; 99: 3962-3970.
97. Varma MR, Varga AJ, Knipp BS, et al. Neutropenia impaires venous thrombosis resolustion in the rat. J Vasc Surg 2003; 38: 1090-1098.
98. Humphries J, McGuiness CL, Smith A, et al. Monocyte chemotactic protein-1(MCP-1) accelerates the organization and resolution of venous thrombi. J Vasc Surg 1999; 30: 894-900.
99. van Ramshorst B, van Bemmelen PS, Honeveld H, et al.
Thrombus regression in deep venous thrombosis.
Quantifiction of spontaneous thrombolysis with duplex scanning. Circulation 1992; 86: 414-419.
100. Ohgi S, Ito K, Tanaka K, et al. Echogenic types of venous thrombi in the common femoral vein by ultrasonic B-mode imaging. Vasc Surg 1991; 25: 253-258.
101. Bradbury A, Ruckley CV. Clinical assessment of patients with venous disease. Gloviczki P, et al. (eds), Handbook of venous disorder, New York, Arnold 2001: 71-83.
102. Hull RD, Raskob GE, Brant RF, et al. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Acrh Intern Med 1997;
157: 2562-2568.
103. Mudge M, Hughes LE. The long term sequelae of deep vein thrombosis. Br J Surg 1978; 65: 692-694.
104. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1-7.
105. Lagerstedt CI, Olsson CG, Fafher BO, et al. Need for long term anticoagulant treatment in a symptomatic calf vein thrombosis. Lancet 1985; 2: 515-518.
106. 応儀成二，池淵正彦，橘球，他．下肢深部静脈血栓症に
おける肺塞栓源の治療．日血外会誌 1995; 5: 143-150.
107. Baglin T, Luddington R, Brown K, et al. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic resk factors: prospective cohort study. Lancet 2003; 362: 523-526.
108. Sakuma M, Okada O, Nakamura M, et al. Recent developments in diagnostic imaging techniques and management for acute pulmonary embolism: multicenter registry by Japanese Society of Pulmonary Embolism Research. Intern Med 2003; 42: 470-476.
109. Watanabe J, Iwabuchi K, Koseki Y, et al. Declining trend in the in-hospital case-fatality rate from acute myocardial infarction in Miyagi prefecture from 1980-1999. Jpn Circ J 2001; 65: 941-946.
110. Miniati M, Prediletto R, Formichi B, et al. Accuracy of clinical assessment in the diagnosis of pulmonary embolism.
Am J Respir Crit Care Med 1999; 159: 864-871.
111. 長谷川浩一，沢山俊民，伊吹山千晴，他．急性肺塞栓症
の早期診断と治療対策―多施設225例の臨床的解析．呼と 循 1993; 41: 773-777.
112. 岡田修，佐久間聖仁，中村真潮，他．肺血栓塞栓症急性
型と慢性肺高血圧型の診断手技と臨床病態: 肺塞栓症研究 会共同作業部会報告．Ther Res 2001; 22: 1481-1486.
113. Palla A, Petruzzelli S, Donnamaria V, ey al. The role of suspicion in the diagnosis of pulmonary embolism. Chest 1995; 107(1 Suppl): 21S-24S.
114. National Cooperative Study. Urokinase-pulmonary embolism trial; clinical and electrocardiographic observations.
Circulation 1973; 47(suppl): II-70-II-65.
115. Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000; 83: 416-420.
116. Wicki J, Perneger TV, Junod A, et al. Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch Intern Med 2001; 161: 92-97.
117. Le Gal G, Righini M, Roy P-M, et al. Prediction of
pulmonary embolism in the emergency department : the revosed Geneva score. Ann Intern Med 2006; 144: 165-171.
118. Chagnon I, Bounameaux H, Aujesky D, et al. Comparison of two clinical prediction rules and implicit assessment among patients with suspected pulmonary embolism. Am J Med 2002; 113: 269-275.
119. Kumasaka N, Sakuma M, Shirato K. Clinical features and predictors of in-hospital mortality inpatients with acute and chronic pulmonary thromboembolism. Intern Med 2000; 39:
1038-1043.
120. Meijer P, Kluft C. The harmonization of quantitative test results of different D-dimer methods. Semin Vasc Med 2005;
5: 321-327.
121. Stein PD, Hull RD, Patel KC, et al. D-dimer for exclusion of acute thrombosis and pulmonary embolism: a systematic review. Ann Intern Med 2004; 140: 589-602.
122. 佐久間聖仁．急性肺血栓塞栓症の診断: 今後の方向性．
Ther Res 2009; 30: 744-747.
123. Sakuma M, Nakamura M, Nakanishi N, et al. Diagnostic a n d t h e r a p e u t i c s t r a t e g y f o r a c u t e p u l m o n a r y thromboembolism. Intern Med 2006; 45: 749-758.
124. Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, et al.
Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 1997; 134: 479-487.
125. Hagspiel KD, Polak JF, Grassi CJ, et al. Pulmonary embolism: comparison of cut-film and digital angiography.
Radiology 1998; 207: 139-145.
126. Stein PD, Athanasoulis C, Alavi A, et al. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 1992; 85: 462-468.
127. Hudson ER, Smith TP, McDermott VG, et al. Pulmonary angiography performed with iopamidol: complications in 1434 patients. Radiology 1996: 198: 61-65.
128. Sostman HD, Stein PD, Gottschalk A, et al. Acute pulmonary embolism: sensitivity and specificity of ventilation-perfusion scintigraphy in PIOPEDⅡstudy.
Radiology 2008; 246: 941-946.
129. Miniati M, Pistolesi M, Marini C, et al. Value of perfusion lung scan in the diagnosis of pulmonary embolism: results of the prospective investigative study of acute pulmonary embolism diagnosis (PISA-PDE). Am J Respir Crit Care Med 1996; 154: 1387-1393.
130. Stein PD, Kayali F, Hull RD. Spiral computed tomography for the diagnosis of acute pulmonary embolism. Thromb Haemost 2007; 98: 713-720.
131. Le Gal G, Righini M, Parent F, et al. Diagnosis and management of subsegmental pulmonary embolism. J Thromb Haemost 2006; 4: 724-731.
132. Roy P-M, Colombet I, Durieux P, et al. Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ 2005; 331: 259-266.
133. Quiroz R, Kucher N, Zou KH, et al. Clinical validity of a negative computed tomography scan in patients with